Results 71 to 80 of about 9,989,625 (302)
Placebo and nocebo phenomena from the perspective of evidence based and person centered medicine [PDF]
Hospital Pharmacology, 2017 Introduction: Placebo and nocebo phenomena in pharmacology are very important, but controversial issues from the perspective of evidence-based medicine (EBM) in many ways.
Jakovljević Miro I.
doaj +1 more source
Filmed clinical cases improved communication skills of student of Pharmacology in Podiatry degree [PDF]
, 2015 Solving clinical case by writing-report lacks of students sympathies and interest in many cases. Make a short film is a novelty that really like to the students and may improve their arguing and planning capacities and their communication skills.
Bellido-Estevez, Inmaculada +5 more
core
Medical Pharmacology and Therapeutics by Derek G. Waller and Anthony P. Sampson [PDF]
, 2017 A thorough and contemporaneous working knowledge of both pharmacology and therapeutics is integral to the current practice of pharmacy, and both disciplines form a significant and rudimentary part of the undergraduate curricula.
Bain, Amie
core +1 more source
AntibodiesThe objective of this work was to develop a population physiologically based pharmacokinetic (popPBPK) model to characterize the variability in the clinical PK of monoclonal antibodies (mAbs) following intravenous (IV) and subcutaneous (SC ...
Mokshada Kumar +5 more
doaj +1 more source
Direct acting anti-hepatitis C virus drugs: Clinical pharmacology and future direction
Journal of Translational Internal Medicine, 2017 Chronic hepatitis C virus (HCV) infection is a leading cause of chronic liver disease. The introduction of direct acting antiviral agents (DAAs) for its treatment represents a major advance in terms of sustained virologic response (SVR) rates and adverse
A. Geddawy +3 more
semanticscholar +1 more source
Clinical Pharmacology of Antihypertensive Therapy for the Treatment of Hypertension in CKD.
American Society of Nephrology. Clinical Journal, 2018 CKD is common and frequently complicated with hypertension both predialysis and in ESKD. As a major modifiable risk factor for cardiovascular disease in this high-risk population, treatment of hypertension in CKD is important.
Arjun D Sinha, R. Agarwal
semanticscholar +1 more source
Tumor necrosis factor inhibitors in psoriatic arthritis. [PDF]
, 2017 INTRODUCTION: Psoriatic arthritis (PsA) is a chronic inflammatory disease that can result in significant disability. With the emergence of tumor necrosis factor inhibitors (TNFi), therapeutic outcomes in PsA have improved substantially.
Kraft, Walter K. +2 more
core +2 more sources
Clinical Pharmacology in HIV Therapy.
American Society of Nephrology. Clinical Journal, 2018 The success of combination antiretroviral therapy in the treatment of HIV-1-positive individuals has shifted clinical attention toward combination antiretroviral drug regimens that optimize tolerability, long-term safety, and durable efficacy.
M. Atta, Sophie De Seigneux, G. Lucas
semanticscholar +1 more source
Advances in Medical Education and Practice, 2014 Joseph P Kitzmiller,1,4 Mitch A Phelps,2 Marjorie V Neidecker,3 Glen Apseloff41Center for Pharmacogenomics, Colleges of Medicine and of Engineering, The Ohio State University Medical Center, 2Colleges of Pharmacy and Medicine, Pharmacoanalytic Shared ...
Kitzmiller JP +3 more
doaj
The effect of weight, body mass index, age, sex, and race on plasma concentrations of subcutaneous sumatriptan: a pooled analysis. [PDF]
, 2016 Objective/backgroundFactors such as body size (weight and body mass index [BMI]), age, sex, and race might influence the clinical response to sumatriptan. We evaluated the impact of these covariates on the plasma concentration (Cp) profile of sumatriptan
Fisher, Dennis M +3 more
core +3 more sources